Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings 
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth 
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development 
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems 
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth 
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks 
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth 
Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy 
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions 
PLEASANTON, Calif., April 23, 2018 -- Title21 Health Solutions, “Title21”, a provider of cloud technology of Enterprise Quality Management Systems (EQMS) and innovative Cellular Therapy Software was awarded a ‘Best Places to Work’ honor for the second consecutive year by the San Francisco Business Times and Silicon Valley Business Times.
“This is a testament to our talented high-performing team and our culture of excellence and empathy. Title21 is dedicated to helping cure cancer and other life-threatening diseases. Our entire team is passionate about making a difference to advance immunotherapy and gene therapy to save lives. We are continuously innovating our technology solutions to better serve the therapies that leading biotech and healthcare institutions are advancing,” said Title21 Co-Founder and CEO, Lynn Fischer. “Our mission requires a strong sense of urgency to support these hopeful clinical breakthroughs, and our dedicated team delivers that excellent care. Title21 is a growing company where employees ‘connect their head and their heart’ in a culture where they can be lifelong learners and build a rewarding career that truly makes a difference.”
Title21’s Enterprise Quality Management Cloud is deployed at top U.S. hospitals, and Title21 launched the first end-to-end software for Blood and Marrow Transplants, Cell and Gene Therapy and Regenerative Medicine available in the market. “It is incredibly rewarding to work directly with the best institutions that are leading the development in cancer treatments for patients who need it most,” stated Dan Waurzyniak, Systems Architect.
Over 500 Bay Area companies participated in an independent, third-party survey that asked employees to grade their workplace anonymously on criteria such as culture, team dynamics, benefits, compensation, management practices and career development opportunities. Companies that make this list are known for having a purpose-driven mission as well as providing its employees with great compensation and a comprehensive benefits package. To learn more about making a difference at Title21 Health Solutions, please visit the Title21’s Careers Page: www.title21.com/careers.
About Title21 Health Solutions
Title21 Health Solutions continues to gain national recognition for its innovative technology to help hospitals, biotechnology and regenerative medicine improve quality, efficiency and patient safety. Title21 is hiring; visit www.Title21.com!
Media Contact Haley Roebuck [email protected]
